Melinda A. Connolly

Measuring Quality of Life in Paediatric Patients

Jeffrey A. Johnson, Melinda A. Connolly, 1999, PharmacoEconomics.

Cost of Care for Individuals with Cystic Fibrosis: A Regression Approach to Determining the Impact of Recombinant Human DNase

Jeffrey A. Johnson, P. Jacobs, J. A. Johnson, 1999, Pharmacotherapy.

Isolated‐ and Beckwith‐Wiedemann syndrome related‐ lateralised overgrowth (hemihypertrophy): Clinical and molecular correlations in 94 individuals

W. Reardon, J. Radley, E. Maher, 2020, Clinical genetics.

Development of a disease-specific health related quality of life instrument for people with cystic fibrosis

Melinda A. Connolly, 2000 .

Health‐Related Quality of Life for Adults with Cystic Fibrosis: A Regression Approach to Assessing the Impact of Recombinant Human DNase

Jeffrey A. Johnson, N. Brown, Melinda A. Connolly, 2000, Pharmacotherapy.